Boston—Favorable results from treatment trials have brought considerable attention to targeted cancer prevention. Meanwhile, research continues to identify proteins important for cancer development and progression, expanding the list of agents that might one day be suitable for healthy individuals at high risk of developing certain types of cancer.
Investigators discussed many of these agents and their targets at the recent Molecular Targets and Cancer Therapeutics International Conference, organized by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer.
Hampton T. Researchers Probe Targeted Agents’ Clinical Potential for Cancer Prevention. JAMA. 2010;303(2):115-116. doi:10.1001/jama.2009.1894